BIOMAT Database Logo BIOMAT Database Logo

[Leptospirosis, Weil's disease]. 1995

Y Sakurai
Division of Gastroenterology, Kantoh-Teishin Hospital, Japan.

UI MeSH Term Description Entries
D008107 Liver Diseases Pathological processes of the LIVER. Liver Dysfunction,Disease, Liver,Diseases, Liver,Dysfunction, Liver,Dysfunctions, Liver,Liver Disease,Liver Dysfunctions
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D003937 Diagnosis, Differential Determination of which one of two or more diseases or conditions a patient is suffering from by systematically comparing and contrasting results of diagnostic measures. Diagnoses, Differential,Differential Diagnoses,Differential Diagnosis
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D013307 Streptomycin An antibiotic produced by the soil actinomycete Streptomyces griseus. It acts by inhibiting the initiation and elongation processes during protein synthesis. Estreptomicina CEPA,Estreptomicina Clariana,Estreptomicina Normon,Strepto-Fatol,Strepto-Hefa,Streptomycin Grünenthal,Streptomycin Sulfate,Streptomycin Sulfate (2:3) Salt,Streptomycin Sulphate,Streptomycine Panpharma,Strepto Fatol,Strepto Hefa
D014895 Weil Disease A severe form of LEPTOSPIROSIS, usually caused by LEPTOSPIRA INTERROGANS SEROVAR ICTEROHAEMORRHAGIAE and occasionally other serovars. It is transmitted to humans by the rat and is characterized by hemorrhagic and renal symptoms with accompanying JAUNDICE. Jaundice, Spirochetal,Leptospirosis, Icterohemorrhagic,Weil's Disease,Disease, Weil,Disease, Weil's,Icterohemorrhagic Leptospirosis,Spirochetal Jaundice,Weils Disease

Related Publications

Y Sakurai
[Leptospirosis (Weil's disease)].
January 1999, Ryoikibetsu shokogun shirizu,
Y Sakurai
Leptospirosis. Weil's disease.
May 1990, Occupational health; a journal for occupational health nurses,
Y Sakurai
Leptospirosis (Weil's disease).
January 1945, Medical bulletin. United States. Army. Forces in the European Theater. Office of the Theater Chief Surgeon,
Y Sakurai
[Icterohemorrhagic leptospirosis (Weil's disease)].
January 1971, Nederlands tijdschrift voor geneeskunde,
Y Sakurai
[Leptospirosis and Weil's disease].
March 1971, Kangogaku zasshi,
Y Sakurai
Leptospirosis or Weil's disease.
July 1955, Virginia medical monthly,
Y Sakurai
[Leptospirosis and Weil's disease].
June 1977, Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases,
Y Sakurai
Leptospirosis icterohaemorrhagica or Weil's disease.
November 1950, Canadian Medical Association journal,
Y Sakurai
Rhabdomyolysis in leptospirosis (Weil's disease).
October 1987, The Journal of infectious diseases,
Y Sakurai
[Leptospirosis (Weil's disease) in Augsburg].
April 2010, Deutsche medizinische Wochenschrift (1946),
Copied contents to your clipboard!